More than 500,000 people in the UK are now on the drugs and could lose between 15-20% of their weight in just a few months.

Ozempic and Wegovy, made by Novo, are on track to become the world’s top-selling drugs by 2025. Yet in 2024, ‘Wegovy Wednesday’ had already become one of the biggest weight-loss trends to sweep the ...

Obesity rates in the UK might start falling by the end of 2024 due to the rising use of weight loss medications like Wegovy and Mounjaro, according to Simple Online Pharmacy, Sky News reports.

The UK's self-regulated system for disclosing payments from drug companies to healthcare professionals and organizations is ...

UK obesity rates ‘may start dropping significantly’ this year because of weight loss jabs - Country may have reached its peak ...

Chemist4U and another online seller, Simple Online Pharmacy, estimate that as many as 500,000 people in the UK currently take either Mounjaro or Wegovy via prescriptions from private online ...

The round is one of Europe’s largest-ever biotech VC deals, signalling investor appetite for the booming weight loss market.

A UK biotechnology startup is entering the crowded obesity drug market, armed with $411 million and a promising ...

Novo Nordisk faces scrutiny over UK pharmacy sponsorships tied to weight-loss drugs, with critics citing conflicts of interest and regulatory breaches.

Financing was co-led by Forbion and General Atlantic, with participants such as RA Capital Management, OrbiMed, and Lilly ...

A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?

Eli Lilly's Tirzepatide Outshines Novo Nordisk's Semaglutide, Yet Brand Recognition Remains Strong for Novo's Products ...